Shambhavi S, Singh H, Ramaprasad G, Khikmatov M, Vankeshwaram V, Ashish K, et al. Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis. World J Oncol [Internet]. 2025 Jul. 26 [cited 2025 Aug. 1];16(4):331-4. Available from: https://wjon.elmerpub.com/wjon/article/view/2613